DEK::AFF2 Fusion-Associated Squamous Cell Carcinoma: A Case Series with Literature Review on an Emerging and Challenging Entity
Authors:
- 23 September 2024
- journal article
- research article
- Published by Springer Nature in Head and Neck Pathology
- Vol. 18 (1) , 1-12
Abstract
Purpose DEK::AFF2 fusion-associated squamous cell carcinoma (DEK::AFF2 SCC), also reported in the literature as low-grade papillary sinonasal (Schneiderian) carcinoma (LGPSC), is a rare, primarily bland-appearing, but locally aggressive neoplasm. Morphologically, these tumors can closely resemble sinonasal papilloma (SP), especially on small or limited biopsy, often leading to misdiagnosis. DEK::AFF2 SCC is devoid of the underlying mutually exclusive EGFR or KRAS driver mutations of SP, suggesting it may represent a distinct unique entity. Methods In this study, we conducted a retrospective search of “unusual” SP reported either as atypical, dysplastic, or suspicious for malignant transformation at our institution in the last 13 years (2010–2023), to identify potential cases of DEK::AFF2 SCC. Results Of the 201 SP cases during this time period, 30 “unusual” SP cases were identified. On morphologic review of these 30 cases, 6 were worrisome for DEK::AFF2 SCC and were selected for AFF2 immunohistochemical stain (IHC), of which 3 cases were positive. All 3 AFF2 IHC positive cases were also positive for DEK::AFF2 fusion by fluorescence in situ hybridization (FISH), thereby, confirming IHC results. Conclusions This study highlights that AFF2 IHC can be an invaluable surrogate marker to FISH in identifying DEK::AFF2 SCC in challenging cases to avoid misdiagnosis. Detailed clinical and pathologic data were collected to gain a better understanding of this emerging challenging entity. A literature review was performed to enrich our knowledge of DEK::AFF2 SCC.Keywords
This publication has 28 references indexed in Scilit:
- Population-Based Results in the Management of Sinonasal and Ventral Skull Base MalignanciesOtolaryngologic Clinics of North America, 2017
- Low-grade Papillary Schneiderian Carcinoma, a Unique and Deceptively Bland Malignant NeoplasmAmerican Journal of Surgical Pathology, 2015
- The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulationMolecular Cancer, 2014
- International comparisons of the incidence and mortality of sinonasal cancerCancer Epidemiology, 2013
- Functional characterization of the AFF (AF4/FMR2) family of RNA-binding proteins: insights into the molecular pathology of FRAXE intellectual disabilityHuman Molecular Genetics, 2011
- Melanoma Proliferation and Chemoresistance Controlled by the DEK OncogeneCancer Research, 2009
- Clinicopathological significance of DEK overexpression in serous ovarian tumorsPathology International, 2009
- Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 FunctionsMolecular and Cellular Biology, 2006
- DEK Expression is Controlled by E2F and Deregulated in Diverse Tumor TypeCell Cycle, 2006
- Dek-can rearrangement in translocation (6;9)(p23;q34).1992